Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.46 |
| ▸ | NAMPT | P43490 | 17/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31488935 | 0.83 | MEN1 (0.55) | TAS1R3TAS1R1TAS1R2NAMPTNPC1 | |
| SCHEMBL31489000 | 0.83 | NAMPT (0.51) | TAS1R3TAS1R1TAS1R2NAMPT | |
| SCHEMBL31488795 | 0.81 | NAMPT (0.67) | NAMPT | |
| Hydrochloric Acid SCHEMBL31488963 | 0.80 | NAMPT (0.66) | NAMPT | |
| SCHEMBL31488821 | 0.79 | NAMPT (0.52) | NAMPTNPC1RAB9A | |
| SCHEMBL31489143 | 0.79 | NAMPT (0.42) | TAS1R3TAS1R1TAS1R2NAMPTROCK2 | |
| SCHEMBL31488803 | 0.79 | NAMPT (0.69) | NAMPTNPC1RAB9AROCK2 | |
| SCHEMBL31488807 | 0.78 | NAMPT (0.51) | NAMPTNPC1RAB9A | |
| SCHEMBL31488991 | 0.77 | NAMPT (0.52) | NAMPTNPC1RAB9A | |
| SCHEMBL31489058 | 0.77 | NAMPT (0.41) | TAS1R3TAS1R1TAS1R2NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072437-A1 | HETEROARYL COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | ALPHINA THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |